233 related articles for article (PubMed ID: 24614158)
1. Synthesis and anticancer activity of novel deoxoartemisinin-glycolipid hybrids.
Min D; Kim M; Ricci J; Jung S; Kim K; Chung WY; Park KK; Jung M
Chem Pharm Bull (Tokyo); 2014; 62(5):446-53. PubMed ID: 24614158
[TBL] [Abstract][Full Text] [Related]
2. Discovery of artemisinin-glycolipid hybrids as anti-oral cancer agents.
Ricci J; Kim M; Chung WY; Park KK; Jung M
Chem Pharm Bull (Tokyo); 2011; 59(12):1471-5. PubMed ID: 22130368
[TBL] [Abstract][Full Text] [Related]
3. Facile synthesis and anticancer activity of C-10 non-acetal deoxoartemisinin dimers.
Phothongkam S; Chancharunee S; Saovapakhiran A; Wichai U; Pohmakotr M
Bioorg Med Chem Lett; 2012 Dec; 22(24):7598-601. PubMed ID: 23103096
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a novel series of artemisinin dimers with potent anticancer activity involving Sonogashira cross-coupling reaction.
Buragohain P; Saikia B; Surineni N; Barua NC; Saxena AK; Suri N
Bioorg Med Chem Lett; 2014 Jan; 24(1):237-9. PubMed ID: 24332623
[TBL] [Abstract][Full Text] [Related]
5. Total synthesis and anticancer activity of highly potent novel glycolipid derivatives.
Jung M; Lee Y; Moon HI; Jung Y; Jung H; Oh M
Eur J Med Chem; 2009 Aug; 44(8):3120-9. PubMed ID: 19342127
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer.
Jung M; Lee S; Ham J; Lee K; Kim H; Kim SK
J Med Chem; 2003 Mar; 46(6):987-94. PubMed ID: 12620075
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and antitumor properties of glycosylated antitumor ether lipid (GAEL)- chlorambucil-hybrids.
Idowu T; Samadder P; Arthur G; Schweizer F
Chem Phys Lipids; 2016 Jan; 194():139-48. PubMed ID: 26188768
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of Tamoxifen-Artemisinin and Estrogen-Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer.
Fröhlich T; Mai C; Bogautdinov RP; Morozkina SN; Shavva AG; Friedrich O; Gilbert DF; Tsogoeva SB
ChemMedChem; 2020 Aug; 15(15):1473-1479. PubMed ID: 32374071
[TBL] [Abstract][Full Text] [Related]
9. Novel spirobicyclic artemisinin analogues (artemalogues): Synthesis and antitumor activities.
Liu G; Song S; Shu S; Miao Z; Zhang A; Ding C
Eur J Med Chem; 2015 Oct; 103():17-28. PubMed ID: 26318055
[TBL] [Abstract][Full Text] [Related]
10. Artemisinin-derived hybrids and their anticancer activity.
Gao F; Sun Z; Kong F; Xiao J
Eur J Med Chem; 2020 Feb; 188():112044. PubMed ID: 31945642
[TBL] [Abstract][Full Text] [Related]
11. Artemisinin-indole and artemisinin-imidazole hybrids: Synthesis, cytotoxic evaluation and reversal effects on multidrug resistance in MCF-7/ADR cells.
Hu Y; Li N; Zhang J; Wang Y; Chen L; Sun J
Bioorg Med Chem Lett; 2019 May; 29(9):1138-1142. PubMed ID: 30837097
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents.
Yu H; Hou Z; Tian Y; Mou Y; Guo C
Eur J Med Chem; 2018 May; 151():434-449. PubMed ID: 29649740
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel ring-contracted artemisinin dimers with potent anticancer activities.
Zhang N; Yu Z; Yang X; Hu P; He Y
Eur J Med Chem; 2018 Apr; 150():829-840. PubMed ID: 29597166
[TBL] [Abstract][Full Text] [Related]
14. Potential sonodynamic anticancer activities of artemether and liposome-encapsulated artemether.
Chen HJ; Huang XR; Zhou XB; Zheng BY; Huang JD
Chem Commun (Camb); 2015 Mar; 51(22):4681-4. PubMed ID: 25691357
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel artemisinin derivatives with potent activities against colorectal cancer in vitro and in vivo.
Wang LL; Kong L; Liu H; Zhang Y; Zhang L; Liu X; Yuan F; Li Y; Zuo Z
Eur J Med Chem; 2019 Nov; 182():111665. PubMed ID: 31494469
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel S-linked dihydroartemisinin derivatives and evaluation of their anticancer activity.
Gour R; Ahmad F; Prajapati SK; Giri SK; Lal Karna SK; Kartha KPR; Pokharel YR
Eur J Med Chem; 2019 Sep; 178():552-570. PubMed ID: 31216504
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisinin.
Jeyadevan JP; Bray PG; Chadwick J; Mercer AE; Byrne A; Ward SA; Park BK; Williams DP; Cosstick R; Davies J; Higson AP; Irving E; Posner GH; O'Neill PM
J Med Chem; 2004 Feb; 47(5):1290-8. PubMed ID: 14971909
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents.
Rane RA; Sahu NU; Gutte SD; Mahajan AA; Shah CP; Bangalore P
Eur J Med Chem; 2013 May; 63():793-9. PubMed ID: 23584542
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
